Does imidazolium salt attenuate thioacetamide-induced liver fibrosis in mice by modulating inflammation and oxidative stress?
These findings indicate DBZIM is a potent therapeutic agent for the treatment of liver fibrosis.
Liver fibrosis is regulated by an epigenetic relay pathway that includes MeCP2, EZH2, and miR132. Reagents that interfere with this pathway might be developed to reduce fibrogenesis in chronic liver disease.